NasdaqGS - Nasdaq Real Time Price USD
Royalty Pharma plc (RPRX)
31.95
+0.26
+(0.82%)
As of 1:31:32 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
2,769,000
--
--
--
--
Operating Cash Flow
2,768,986
2,768,986
2,987,802
2,143,980
2,017,536
Investing Cash Flow
-2,678,115
-2,678,115
-2,072,789
-1,029,421
-1,870,280
Financing Cash Flow
361,145
361,145
-2,148,754
-944,856
385,112
End Cash Position
929,026
929,026
477,010
1,710,751
1,541,048
Issuance of Debt
1,471,235
1,471,235
350,000
--
1,272,533
Repayment of Debt
--
--
-1,350,000
--
--
Repurchase of Capital Stock
-229,651
-229,651
-304,759
--
--
Free Cash Flow
2,768,986
2,768,986
2,987,802
2,143,980
2,017,536
12/31/2021 - 6/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYTK Cytokinetics, Incorporated
40.06
+5.42%
GMAB Genmab A/S
20.47
+1.66%
ARGX argenx SE
601.66
+1.18%
ASMB Assembly Biosciences, Inc.
10.52
+1.05%
IONS Ionis Pharmaceuticals, Inc.
29.24
+0.48%
JAZZ Jazz Pharmaceuticals plc
107.92
+3.58%
BPMC Blueprint Medicines Corporation
85.27
-0.63%
ALNY Alnylam Pharmaceuticals, Inc.
240.73
-0.51%
INCY Incyte Corporation
58.40
+0.69%
PTCT PTC Therapeutics, Inc.
49.58
-0.74%